Evaluation of an individualized education program in pituitary diseases: a pilot study

in European Journal of Endocrinology
View More View Less
  • 1 Department of Endocrinology, Assistance Publique-Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares de l’hypophyse HYPO, 13005 Marseille, France
  • 2 Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM) U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), Marseille, France

Correspondence should be addressed to T Brue; Email: thierry.brue@univ-amu.fr
Restricted access

Introduction

The low prevalence of pituitary diseases makes patient autonomy crucial, and self-management programs should be more common.

Objectives

To assess the efficacy of an education program for patients with pituitary diseases in terms of patients’ quality of life, satisfaction and goal attainment.

Design and methods

Adult patients with pituitary disorders were recruited in a tertiary referral center and chose at least three of eight possible sessions on various topics, from disease management to psychosocial issues. Patients were included if they attended at least three sessions between 2012 and 2016 and completed the initial, final, and follow-up questionnaires. Data on quality of life (SF36), satisfaction and goal attainment were analyzed.

Results

Fifty-three patients were included (33 women; mean age, 53.5 years). There were a significant quality of life improvements in terms of physical and psychic limitation scores at the final assessment that persisted at follow-up evaluation. Most patients reached their objectives, especially those on sharing experiences and improving autonomy and self-confidence. More than half set new objectives at the end of the program, the most popular one being to reinforce their knowledge of their pituitary disease, its evolution and treatment (17.1% of patients). The mean overall satisfaction score was 3.75/4. At follow-up evaluation, patients reported improved self-management of pituitary disease (3.6/5) and improved self-efficacy (3.8/5).

Conclusion

Individualizing the educational objectives of patients with pituitary disease improves the way they live with their disease. If confirmed in other cohorts, this approach could become the gold standard for education programs in rare endocrine diseases.

 

     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 129 129 129
Full Text Views 23 23 23
PDF Downloads 13 13 13
  • 1

    Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, Beuschlein F, Willenberg HS, Quinkler M & Allolio B High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. Journal of Clinical Endocrinology and Metabolism 2015 100 407416. (https://doi.org/10.1210/jc.2014-3191)

    • Search Google Scholar
    • Export Citation
  • 2

    Lagger G, Pataky Z & Golay A Efficacy of therapeutic patient education in chronic diseases and obesity. Patient Education and Counseling 2010 79 283286. (https://doi.org/10.1016/j.pec.2010.03.015)

    • Search Google Scholar
    • Export Citation
  • 3

    Osborn RL, Demoncada AC & Feuerstein M Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. International Journal of Psychiatry in Medicine 2006 36 1334. (https://doi.org/10.2190/EUFN-RV1K-Y3TR-FK0L)

    • Search Google Scholar
    • Export Citation
  • 4

    Warsi A, Wang PS, LaValley MP, Avorn J & Solomon DH Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Archives of Internal Medicine 2004 164 16411649. (https://doi.org/10.1001/archinte.164.15.1641)

    • Search Google Scholar
    • Export Citation
  • 5

    Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH & Stratakis CA Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2016 101 364389. (https://doi.org/10.1210/jc.2015-1710)

    • Search Google Scholar
    • Export Citation
  • 6

    Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL & Kasperlik-Zaluska A Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. Journal of Internal Medicine 2014 275 104115. (https://doi.org/10.1111/joim.12162)

    • Search Google Scholar
    • Export Citation
  • 7

    Guignat L Therapeutic patient education in adrenal insufficiency. Annales D’endocrinologie 2018 79 167173. (https://doi.org/10.1016/j.ando.2018.03.002)

    • Search Google Scholar
    • Export Citation
  • 8

    Burman P, Mattsson AF, Johannsson G, Höybye C, Holmer H, Dahlqvist P, Berinder K, Engström BE, Ekman B & Erfurth EM Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. Journal of Clinical Endocrinology and Metabolism 2013 98 14661475. (https://doi.org/10.1210/jc.2012-4059)

    • Search Google Scholar
    • Export Citation
  • 9

    Burger-Stritt S, Kardonski P, Pulzer A, Meyer G, Quinkler M & Hahner S Management of adrenal emergencies in educated patients with adrenal insufficiency – a prospective study. Clinical Endocrinology 2018 89 2229. (https://doi.org/10.1111/cen.13608)

    • Search Google Scholar
    • Export Citation
  • 10

    Schad R, Schneider PJ & Nold EG Reimbursable pharmacy teaching program for adrenalectomy patients. American Journal of Hospital Pharmacy 1979 36 12121214. (https://doi.org/10.1093/ajhp/36.9.1212)

    • Search Google Scholar
    • Export Citation
  • 11

    Guignat L Therapeutic education in adrenal insufficiency: a tool insufficiently used to prevent or treat early acute adrenal insufficiency. Presse Medicale 2014 43 444452. (https://doi.org/10.1016/j.lpm.2014.01.008)

    • Search Google Scholar
    • Export Citation
  • 12

    Repping-Wuts HJWJ, Stikkelbroeck NMML, Noordzij A, Kerstens M & Hermus ARMM A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis. European Journal of Endocrinology 2013 169 1722. (https://doi.org/10.1530/EJE-12-1094)

    • Search Google Scholar
    • Export Citation
  • 13

    Vidmar AP, Weber JF, Monzavi R, Koppin CM & Kim MS Improved medical-alert ID ownership and utilization in youth with congenital adrenal hyperplasia following a parent educational intervention. Journal of Pediatric Endocrinology and Metabolism 2018 31 213219. (https://doi.org/10.1515/jpem-2017-0435)

    • Search Google Scholar
    • Export Citation
  • 14

    Hahner S, Burger-Stritt S & Allolio B Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency. European Journal of Endocrinology 2013 169 1471 54. (https://doi.org/10.1530/EJE-12-1057)

    • Search Google Scholar
    • Export Citation
  • 15

    Bancos I, Hahner S, Tomlinson J & Arlt W Diagnosis and management of adrenal insufficiency. Lancet: Diabetes and Endocrinology 2015 3 216226. (https://doi.org/10.1016/S2213-8587(1470142-1)

    • Search Google Scholar
    • Export Citation
  • 16

    Haugland T, Veenstra M, Vatn MH & Wahl AK Improvement in stress, general self-efficacy, and health related quality of life following patient education for patients with neuroendocrine tumors: a pilot study. Nursing Research and Practice 2013 2013 695820. (https://doi.org/10.1155/2013/695820)

    • Search Google Scholar
    • Export Citation
  • 17

    De Bucy C, Guignat L, Niati T, Bertherat J & Coste J Health-related quality of life of patients with hypothalamic-pituitary-adrenal axis dysregulations: a cohort study. European Journal of Endocrinology 2017 177 18. (https://doi.org/10.1530/EJE-17-0048)

    • Search Google Scholar
    • Export Citation
  • 18

    Kyriakakis N, Lynch J, Gilbey SG, Webb SM & Murray RD Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: results from a 5-years prospective study. Clinical Endocrinology 2017 86 806815. (https://doi.org/10.1111/cen.13331)

    • Search Google Scholar
    • Export Citation
  • 19

    van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, van Aken MO, Havekes B, Pereira AM & Pijl H Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clinical Endocrinology 2008 69 775784. (https://doi.org/10.1111/j.1365-2265.2008.03288.x)

    • Search Google Scholar
    • Export Citation
  • 20

    Andela CD, Repping-Wuts H, Stikkelbroeck NMML, Pronk MC, Tiemensma J, Hermus AR, Kaptein AA, Pereira AM, Kamminga NGA & Biermasz NR Enhanced self-efficacy after a self-management programme in pituitary disease: a randomized controlled trial. European Journal of Endocrinology 2017 177 5972. (https://doi.org/10.1530/EJE-16-1015)

    • Search Google Scholar
    • Export Citation
  • 21

    Martínez-Momblán MA, Gómez C, Santos A, Porta N, Esteve J, Úbeda I, Halperin I, Campillo B, Guillaumet M & Webb SM A specific nursing educational program in patients with Cushing’s syndrome. Endocrine 2016 53 199209. (https://doi.org/10.1007/s12020-015-0737-0)

    • Search Google Scholar
    • Export Citation
  • 22

    Andela CD, Niemeijer ND, Scharloo M, Tiemensma J, Kanagasabapathy S, Pereira AM, Kamminga NGA, Kaptein AA & Biermasz NR Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL. Pituitary 2015 18 86100. (https://doi.org/10.1007/s11102-014-0561-1)

    • Search Google Scholar
    • Export Citation
  • 23

    Andela CD, Lobatto DJ, Pereira AM, van Furth WR & Biermasz NR How non-functioning pituitary adenomas can affect health-related quality of life: a conceptual model and literature review. Pituitary 2018 21 208216. (https://doi.org/10.1007/s11102-017-0860-4)

    • Search Google Scholar
    • Export Citation
  • 24

    Andela CD, Scharloo M, Pereira AM, Kaptein AA & Biermasz NR Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 2015 18 752776. (https://doi.org/10.1007/s11102-015-0636-7)

    • Search Google Scholar
    • Export Citation
  • 25

    Newman S, Steed L & Mulligan K Self-management interventions for chronic illness. Lancet 2004 364 15231537. (https://doi.org/10.1016/S0140-6736(0417277-2)

    • Search Google Scholar
    • Export Citation
  • 26

    Lobatto DJ, Steffens ANV, Zamanipoor Najafabadi AH, Andela CD, Pereira AM, van den Hout WB, Peul WC, Vliet Vlieland TPM, Biermasz NR & van Furth WR Work disability and its determinants in patients with pituitary tumor-related disease. Pituitary 2018 21 593604. (https://doi.org/10.1007/s11102-018-0913-3)

    • Search Google Scholar
    • Export Citation
  • 27

    Hahner S, Loeffler M, Fassnacht M, Weismann D, Koschker AC, Quinkler M, Decker O, Arlt W & Allolio B Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. Journal of Clinical Endocrinology and Metabolism 2007 92 39123922. (https://doi.org/10.1210/jc.2007-0685)

    • Search Google Scholar
    • Export Citation
  • 28

    Andela CD, Tiemensma J, Kaptein AA, Scharloo M, Pereira AM, Kamminga NG & Biermasz NR The partner’s perspective of the impact of pituitary disease: looking beyond the patient. Journal of Health Psychology 2019 24 16871697. (https://doi.org/10.1177/1359105317695427)

    • Search Google Scholar
    • Export Citation
  • 29

    Dibley L, Norton C & Jones R Informing a patient education programme for GORD: a literature review. Gastrointestinal Nursing 2009 7 2837. (https://doi.org/10.12968/gasn.2009.7.5.42907)

    • Search Google Scholar
    • Export Citation
  • 30

    Lobatto DJ, van den Hout WB, Zamanipoor Najafabadi AH, Steffens ANV, Andela CD, Pereira AM, Peul WC, van Furth WR, Biermasz NR & Vliet Vlieland TPM Healthcare utilization and costs among patients with non-functioning pituitary adenomas. Endocrine 2019 64 330340. (https://doi.org/10.1007/s12020-019-01847-7)

    • Search Google Scholar
    • Export Citation